Register Login

Emicizumab Laboratory Assay Review

Here is a comprehensive review of the 2017 hemophilia A therapeutic emicizumab [HEMLIBRA]. The author, Michael A. Nardi, MD, NYU Langone Health, details the effects of emicizumab on standard clot-based laboratory assays and the need for chromogenic substrate test methods. Click Nardi MA. Emicizumab and the clinical laboratory. Clin Lab Sci 2017; 30.DOI:

Comments (0)
Bleeding Disorders

No comments here.

Leave a Reply